Class action filed against Walgreens

Listen to this article

Bragar Eagel & Squire, P.C., announced Wednesday that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Walgreens securities between October 12, 2023 and June 26, 2024.

According to the firm, investors have until September 10, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint alleges that on June 27, 2024, Walgreens announced 3Q24 financial results and reduced its revenue guidance for the fourth quarter and full fiscal year 2024. The Company attributed its results and lowered guidance on the “significant challenges in the U.S. Retail Pharmacy business stemming from a worse-than-expected consumer environment and challenging pharmacy industry trends.”

Following this news, Walgreens stock began trading more than 20% lower than the previous day’s closing price of $15.65 per share.

If you purchased or otherwise acquired Walgreens shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Walgreens declined to comment.